Homozygous familial hypercholesterolemia with cutaneous xanthomas in a child
- PMID: 34982846
- DOI: 10.1111/ijd.16033
Homozygous familial hypercholesterolemia with cutaneous xanthomas in a child
Comment on
-
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.Eur Heart J. 2014 Aug 21;35(32):2146-57. doi: 10.1093/eurheartj/ehu274. Epub 2014 Jul 22. Eur Heart J. 2014. PMID: 25053660 Free PMC article.
References
-
- Wiegman A, Gidding SS, Watts GF, et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J 2015; 36: 2425-2437.
-
- Cuchel M, Bruckert E, Ginsberg HN, et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J 2014; 35: 2146-2157.
-
- Snozek CL, Lagerstedt SA, Khoo TK, et al. LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance. Eur J Hum Genet 2009; 17: 85-90.
-
- Lozano P, Henrikson NB, Dunn J, et al. US Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the US Preventive Services Task Force Rockville (MD). US: Agency for Healthcare Research and Quality, 2016.
-
- Raal FJ, Pilcher GJ, Panz VR, et al. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid lowering therapy. Circulation 2011; 124: 2202-2207.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources